Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Other Operating Expenses of -$23.2 million for Q3 2025, down 67380.18% year-over-year from N/an in Q3 2024, and down 67380.18% quarter-over-quarter from $34453.5 in Q3 2024.
Aurora Cannabis (ACB) Other Operating Expenses (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Other Operating Expenses for 8 consecutive years, with -$23.2 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Operating Expenses fell 67380.18% year-over-year to -$23.2 million; the TTM figure through Mar 2026 stood at -$23.2 million (down 993.81% YoY), while the FY2026 annual figure was $53.0 million, down 2.38% from the prior year.
- Other Operating Expenses slipped to -$23.2 million in Q3 2025 per ACB's latest filing, from $34453.5 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $764.0 million in Q2 2023 and bottomed at -$5.2 billion in Q3 2023.
- Historically, Other Operating Expenses has averaged -$546.1 million across 5 years, with a median of -$23.2 million in 2025.
- Annual changes were most pronounced in 2021 — Other Operating Expenses soared 8371.75% — and 2025, when it slumped 67380.18%.
- Aurora Cannabis' Other Operating Expenses stood at $25.1 million in 2021, then plunged by 1433.93% to -$334.3 million in 2022, then tumbled by 1447.95% to -$5.2 billion in 2023, then soared by 100.0% to $34453.5 in 2024, then plunged by 67380.18% to -$23.2 million in 2025.
- Business Quant data shows ACB's Other Operating Expenses at -$23.2 million in Q3 2025, $34453.5 in Q3 2024, and $2.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Aurora Cannabis | 233.15 Mn | 160.83 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -23.18 Mn |
| Sep 30, 2024 | 34,453.51 |
| Jun 30, 2024 | 2.56 Mn |
| Sep 30, 2023 | -5.18 Bn |
| Jun 30, 2023 | 764.00 Mn |
| Dec 31, 2022 | -334.31 Mn |
| Sep 30, 2022 | -347.95 Mn |
| Jun 30, 2022 | -358.80 Mn |
| Mar 31, 2022 | -585.59 Mn |
| Dec 31, 2021 | 25.06 Mn |
| Sep 30, 2021 | 25.56 Mn |
| Dec 31, 2020 | -302,986.59 |
| Sep 30, 2020 | -2.54 Mn |
| Jun 30, 2020 | -524.49 Mn |
| Mar 31, 2020 | 36.24 Mn |
| Dec 31, 2019 | 631.93 Mn |
| Sep 30, 2019 | 49.96 Mn |
| Mar 31, 2019 | -6.77 Mn |
| Dec 31, 2018 | 524,272.89 |
| Sep 30, 2018 | 61.62 Mn |